Sign in

CIK 0001359931

  • Non-accelerated filer
  • Smaller reporting company

Protara Therapeutics, Inc.

Sign in to watch
Ticker
TARA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
204580525
Phone
+1 646-844-0337
Business address
345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK, NY, 10010
Former names
Protara Therapeutics, Inc., ArTara Therapeutics, Inc., PROTEON THERAPEUTICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 31 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-11-30 Flynn James E Director Sale −110,557 $1.75 $193K 0
2017-11-15 NOYES TIMOTHY P President and CEO Returned to the company −5,650 $1.70 $10K 28,742
2017-11-14 NOYES TIMOTHY P President and CEO Returned to the company −4,350 $1.69 $7K 34,392
2017-11-14 Eldridge, George Arthur Sr VP, CFO, Treasr, Asst Secy Purchase +295 $1.69 $499 1,545
2017-11-14 BOHLIN GAREN G Director Grant or award +3,812 $1.89 $7K 53,312
2017-11-13 BOHLIN GAREN G Director Grant or award +25,700 $1.92 $49K 49,500
2017-11-10 BOHLIN GAREN G Director Grant or award +23,800 $1.96 $47K 23,800
2017-10-16 NOYES TIMOTHY P President and CEO Returned to the company −10,000 $2.31 $23K 38,742
2017-09-15 NOYES TIMOTHY P President and CEO Returned to the company −5,146 $1.48 $8K 48,742
2017-09-14 NOYES TIMOTHY P President and CEO Returned to the company −4,854 $1.45 $7K 53,888
2017-08-02 LEFF JONATHAN S Director Grant or award · Stock Option (Right to Buy) +13,333 13,333
2017-08-02 Flynn James E Director Grant or award · Stock Option (Right to Buy) +13,333 13,333
2017-06-30 Toner E. Scott Senior VP of Marketing Grant or award −8,718 $1.30 $11K 8,853
2017-06-30 Kowalsky Matthew Paul VP, Legal and Secretary Grant or award +10,000 $1.30 $13K 13,097
2017-06-30 Eldridge, George Arthur Sr VP, CFO, Treasr, Asst Secy Grant or award +10,000 $1.30 $13K 12,750
2017-06-30 Burke Steven Keith SVP and Chief Medical Officer Grant or award −10,000 $1.30 $13K 105,535
2017-06-22 TVM Life Science Ventures VI GmbH & Co KG Director Purchase · Series A Convertible Preferred Stock +372 $1,000.00 $372K 500
2017-06-22 Freund John Gordon Director Purchase · Series A Convertible Preferred Stock +1,054 $1,000.00 $1.1M 1,054
2017-06-22 Haines Timothy Director Purchase · Series A Convertible Preferred Stock +2,526 $1,000.00 $2.5M 2,526
2017-06-22 Abingworth LLP 10% owner Purchase · Series A Convertible Preferred Stock +2,526 $1,000.00 $2.5M 2,526

Page 21 of 24 · 473 trades